Post-marketing surveillance of Levofloxacin 0.5% ophthalmic solution for external ocular infections

Kanda Y., Kayama T., Okamoto S., Hashimoto M., Ishida C., Yanai T., Fukumoto M., Kunihiro E.

2012
Drugs in R and D

View publication

Therapeutic Area

Front of the eye (FOTE)
Categories

Clinical development

Affiliations

Post-Marketing Surveillance Group, Santen Pharmaceutical Co., Ltd., Osaka, Japan; Drug Safety Information Group, Santen Pharmaceutical Co., Ltd., Osaka, Japan; Safety Vigilance Group, Santen Pharmaceutical Co., Ltd., 3-9-19 Shimo-Shinjo, Osaka 533-8651, Japan

Related Publications

Multimodal Approach in Dry Eye Disease Combining In Vivo Confocal Microscopy and HLA-DR Expression

Blautain, B.; Rabut, G.; Dupas, B.; Riancho, L.; Liang, H.; Luzu, J.: Labbé, A.; Garrigue J.-S.; Brignole-Baudouin, F.; Baudouin, C.; Kessal, K.

Trans-eyelid distribution of epinastine to the conjunctiva following eyelid application in rabbits

Mochizuki T.; Hata T.; Mori N.; Yamazaki T.; Noto T.; Mano H.

Burden of Vernal Keratoconjunctivitis in the United States: A Retrospective Claims Database Analysis

Koo E.B.; Yu T.M.; Layton A.J.; Babineaux S.; Fung S.

View all Front of the eye (FOTE) publications

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022